53 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

ARGX

argenx
€384.14-3.3%2.5%€21.0b€477.74PS18xE56.3%n/a

SBFM

Sunshine Biopharma
US$0.09616.6%-85.3%US$9.6mUS$3.00PB0.4xE134.4%n/a

KRTX

Karuna Therapeutics
US$329.833.3%80.7%US$12.6bUS$326.92PS19238.9xE60.1%n/a

IOVA

Iovance Biotherapeutics
US$13.22-4.0%140.4%US$3.7bUS$26.00PS3105.5xE61.7%n/a

RYTM

Rhythm Pharmaceuticals
US$43.618.9%135.5%US$2.5bUS$57.22PS34.3xE61.1%n/a

CASI

CASI Pharmaceuticals
US$3.13-10.8%11.8%US$40.4mUS$12.00PS1.2xE57.6%n/a

MESO

Mesoblast
AU$5.85-11.2%-16.9%AU$1.0bAU$7.07PS92.1xE64.4%n/a

VCEL

Vericel
US$50.34-1.8%63.8%US$2.4bUS$53.07PS12.3xE49.4%n/a

GNFT.F

Genfit
€2.980%n/a€161.1m€8.63PS4.2xE54.7%n/a

ARGN.F

argenx
€383.740%n/a€21.0b€477.24PS18xE56.3%n/a

FRLN

Freeline Therapeutics Holdings
US$6.48-0.2%-21.7%US$28.3mUS$8.25PS45.4xE60.7%n/a

IMMP

Immutep
AU$2.675.1%66.9%AU$481.5mAU$8.54PS122.5xE60.3%n/a

SRRA

Sierra Oncology
US$54.990.06%179.4%US$1.3bUS$55.00PB5.1xE69.5%n/a

CASB.F

CanSino Biologics
HK$2.1012.9%-59.8%HK$9.2bHK$2.89PS12.2xE124.2%0%

PTGX

Protagonist Therapeutics
US$29.134.1%58.8%US$1.6bUS$43.00PS28.3xE50.0%n/a

LEGN

Legend Biotech
US$56.36-0.1%11.5%US$10.0bUS$86.32PS36xE61.9%n/a

ARCT

Arcturus Therapeutics Holdings
US$31.66-1.7%17.4%US$832.5mUS$67.89PS5.1xE60.7%n/a

BPMC

Blueprint Medicines
US$92.200.7%108.6%US$5.6bUS$97.38PS22.6xE66.2%n/a

YS

YS Biopharma
US$0.8513.5%-43.3%US$165.7mUS$4.29PS2.1xE56.6%n/a

GERN

Geron
US$3.4310.6%70.6%US$2.0bUS$5.08PS8522.5xE62.1%n/a

ADMA

ADMA Biologics
US$6.11-5.1%89.2%US$1.4bUS$8.38PS5.4xE32.5%n/a

ICPT

Intercept Pharmaceuticals
US$19.000.1%19.1%US$794.7mUS$19.00PS2.5xE42.4%n/a

DVAX

Dynavax Technologies
US$12.02-2.4%11.7%US$1.6bUS$24.67PS6.8xE41.6%n/a

PHAR

Pharming Group
€10.00-7.1%-16.1%€663.7m€20.29PS2.9xE52.9%n/a
Page 2 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.